| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,893,000
|
3,410,000
|
3,332,000
|
3,222,000
| | Cost of Revenue | 701,000 | 700,000 | 673,000 | 650,000 | | |
Gross Profit
|
3,192,000
|
2,710,000
|
2,659,000
|
2,572,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 588,000 | 687,000 | 563,000 | 591,000 |
|
Non Recurring | 293,000 | 507,000 | 301,000 | 1,233,000 |
|
Others | 1,022,000 | 1,028,000 | 979,000 | 1,027,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,289,000
|
488,000
|
816,000
|
(279,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (185,000) | 239,000 | (241,000) | 563,000 |
|
Earnings Before Interest And Taxes | 1,104,000 | 727,000 | 575,000 | 284,000 |
|
Interest Expense | 164,000 | 181,000 | 185,000 | 190,000 |
|
Income Before Tax | 940,000 | 546,000 | 390,000 | 94,000 |
|
Income Tax Expense | 456,000 | 356,000 | 248,000 | 164,000 |
|
Minority Interest | (24,000) | 13,000 | (21,000) | (19,000) |
|
|
|
Net Income From Continuing Ops | 460,000 | 203,000 | 121,000 | (89,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
460,000
|
203,000
|
121,000
|
(89,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
460,000
|
203,000
|
121,000
|
(89,000)
|
|
1.35%